News Hualan Group Co., Ltd.

Equities

301027

CNE100004MH7

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
8.22 ^CNY	+1.36%		-2.61%	-34.29%

07:03am	Hualan Biological Engineering's Blood Centers Get License to Operate	MT
04-23	Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hualan Biological Engineering's Blood Centers Get License to Operate	06:03am	MT
Hualan Group Co., Ltd. Proposes Final Dividend for 2023	04-23	CI
Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates	04-02	MT
Hualan Biological Engineering Obtains Blood Collection License	02-02	MT
Hualan Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Hualan Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood	16/08/23	MT
Hualan Group Unit Secures Construction Enterprise Qualification Certificate	04/08/23	MT
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection	07/07/23	MT
Hualan Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023	14/06/23	CI
Hualan Biological Engineering Obtains Blood Plasma Collection License	31/05/23	MT
Hualan Group Co., Ltd. Approves Cash Dividend for the Year 2022	17/05/23	CI
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug	05/05/23	MT
Hualan Group Co., Ltd. Proposes Cash Final Dividend for 2022	25/04/23	CI
Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23	CI
Hualan Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/04/23	CI
Hualan Biological Bacterin to Return to Profit in Q1	10/04/23	MT
Hualan Biological Bacterin Gets Certification for Tetanus Vaccine	28/02/23	MT
Hualan Biological Bacterin Registers Freeze-Dried Human Rabies Vaccine	01/02/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hualan Group Co., Ltd.

Equities

301027

CNE100004MH7

Summary

Filters